Atrioventricular block

Last reviewed: 26 Apr 2022
Last updated: 26 Nov 2021

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • age >50-60 years
  • syncope
  • heart rate <40 bpm
  • pre-syncope
More key diagnostic factors

Other diagnostic factors

  • male sex
  • fatigue
  • dyspnoea
  • chest pain, palpitations, and nausea or vomiting
  • high (less commonly, low) blood pressure
  • cannon A waves
  • hypoxaemia
  • family history of AV block
  • features of Lyme disease
Other diagnostic factors

Risk factors

  • age-related degenerative changes in the conduction system
  • increased vagal tone
  • AV-nodal blocking agents
  • chronic stable coronary artery disease
  • acute coronary syndrome
  • recent cardiac surgery, intervention, or ablation
  • congestive heart failure (CHF)
  • hypertension
  • cardiomyopathy
  • left ventricular hypertrophy
  • acid-base or electrolyte disturbance
  • neuromuscular disorders
  • sarcoidosis
  • giant cell myocarditis
  • cardiac tuberculosis
  • lyme disease
  • infective endocarditis
  • hypoxemia
  • blunt cardiac injury
  • some indigenous medicines
More risk factors

Diagnostic investigations

1st investigations to order

  • 12-lead ECG
  • serum troponin
  • serum potassium
  • serum calcium
  • serum pH
  • serum digitalis level
More 1st investigations to order

Investigations to consider

  • 24-hour ambulatory monitoring or event monitoring
  • chest x-ray
  • transthoracic echocardiogram
  • serological testing for Lyme disease
  • tilt-table testing
  • electrophysiological study
  • cardiac stress testing
  • coronary angiography
  • serum CK-MB
More investigations to consider

Treatment algorithm

ACUTE

first-degree AV block or type I second-degree AV block

type II second-degree AV block or third-degree AV block

Contributors

Authors

Sanjiv Petkar, MD, FRCP

Consultant Cardiologist/Electrophysiologist

Royal Wolverhampton NHS Trust

Heart and Lung Centre

New Cross Hospital

Wolverhampton

UK

Disclosures

SP has received speaker's honoraria from Bayer, Bristol-Myers Squibb, MSD, and Pfizer. SP has received hospitality and/or accommodation from Bayer, Medtronic, St Jude, and Boston Scientific for attending conferences or meetings.

Dibbendhu Khanra, MD, DM Cardiology

International Clinical Fellow in Electrophysiology and Devices

Royal Wolverhampton NHS Trust

Heart and Lung Centre

New Cross Hospital

Wolverhampton

UK

Disclosures

DK declares that he has no competing interests.

Gaurav Panchal, MBBS, MRCP

Specialist Registrar in Cardiology/Electrophysiology

Royal Wolverhampton NHS Trust

Heart and Lung Centre

New Cross Hospital

Wolverhampton

UK

Disclosures

GP declares that he has no competing interests.

Acknowledgements

Dr Petkar, Dr Khanra, and Dr Panchal would like to gratefully acknowledge Dr Pathiraja, Dr Aziz, Dr Susan S. Kim, Dr John F. Beshai, and Dr Stephen L. Archer, previous contributors to this topic. JP, AA, SSK, JFB, and SLA declare that they have no competing interests.

Peer reviewers

Bradley P. Knight, MD

Professor of Medicine

Section of Cardiology

Director

Cardiac Electrophysiology

University of Chicago Medical Center

Chicago

IL

Disclosures

BPK declares that he has no competing interests.

Martin C. Burke, DO

Associate Professor of Medicine

Section of Cardiology

Cardiac Electrophysiology

University of Chicago Medical Center

Chicago

IL

Disclosures

MCB declares that he has no competing interests.

Nick Gall, MSc, MD, FRCP

Consultant Cardiologist

King’s College Hospital

London

UK

Disclosures

NG declares that he has no competing interests.

Thomas A. Dewland, MD

Associate Professor of Medicine

University of California

San Francisco

CA

Disclosures

TAD declares that he has no competing interests.

  • Atrioventricular block images
  • Differentials

    • Junctional rhythm
    • Supraventricular tachycardia (SVT)
    • Atrial fibrillation or multifocal atrial tachycardia (MAT)
    More Differentials
  • Guidelines

    • 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
    • 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy
    More Guidelines
  • Patient leaflets

    Atrial fibrillation: what is it?

    Atrial fibrillation: what treatments work?

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer